BridgeMD
New treatment option for Upper Aerodigestive Tract Cancer
Official title Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodigestive Tract Cancer
ClinicalTrials.gov ID: NCT06184880
What this study is testing
- What it's testing
- APAORL2 study aims to evaluate the efficacy of a physical activity program on the sedentary and physical activity level during the 18-month program. APAORL2 study is a randomized, open label, controlled, monocentric, intervention study that will be conducted among 96 patients treated for localized upper aerodigestive tract cancer.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients ≥18 years
- newly diagnosed, histologically proven Upper Aerodigestive Tract Cancer, non-metastatic,
- life expectancy ≥18 months
- having a smartphone, tablet or computer with an internet connection enabling remote physical Activity sessions for the experimental group
You likely can't join if
- Presenting a contraindication to moderate physical activity
- Deprived of their liberty by court or administrative decision
- Unable to be followed for medical, social, family, geographic or psychological reasons for the duration of the study,
The study team makes the final eligibility decision.
Where it's taking place
- Valence, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valence, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.